Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.
Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.
When the Food and Drug Administration (FDA) announced in March 2017 that it was requiring Johnson & Johnson and its subsidiary Janssen Pharmaceuticals to add a boxed warning – the strongest warning required by the FDA – to the labels of its type 2 diabetes medication Invokana regarding an increased risk of amputations in users, some doctors and hospital-affiliated medical groups rushed to take patients off the drug. Amputation is already a risk for diabetics. Why worsen the odds? The FDA Safety Communication informed consumers that leg and foot amputations occurred about twice as often in patients taking Invokana than ... Read More
Attorneys representing consumers in a multidistrict litigation (MDL) accusing testosterone treatment manufacturers of failing to warn that their products carried cardiovascular risks asked an Illinois federal judge to fine AbbVie Inc., nearly a half million dollars for misusing a records-collecting process to challenge almost 1,000 cases. The plaintiffs’ attorneys told U.S. District Judge Matthew Kennelly that AbbVie, maker of the top-selling AndroGel testosterone replacement therapy, was improperly using the plaintiff profile forms in an attempt to have the cases dismissed. As a result, the plaintiffs’ steering committee has spent tremendous time and effort to respond to the drug company’s issues. ... Read More
Opioids are responsible for 20 percent of deaths among young adults, according to a new study published in JAMA Network Open. The study, conducted by researchers from St. Michael’s Hospital in Toronto, Canada, found that the opioid epidemic is taking a significant toll on young adults in the U.S. between the ages of 24 and 35. In fact, opioid overdoses are killing one in five of them – a 292 percent increase since 2001. “Despite the amount of attention that has been placed on this public health issue, we are increasingly seeing the devastating impact that early loss of life ... Read More
AbbVie Inc., prevailed in the latest bellwether trial accusing the company’s testosterone treatment AndroGel of causing heart attacks, strokes and blood clots, but AbbVie and other testosterone manufacturers still face thousands more lawsuits consolidated in a multidistrict litigation in the U.S. District Court for the Northern District of Illinois. This is the third of five bellwether trials that have been won by testosterone makers. The other two have resulted in a total of $143 million in verdicts for the plaintiffs. The latest trial involved the case of Rober Rowley who was prescribed AndroGel in 2012 to treat fatigue. Years earlier, ... Read More
Children with severe mental disorders who are treated with antipsychotics including Rispedal are at an increased risk of gaining a significant amount of weight in the belly and becoming resistant to insulin, conditions that contribute to early-onset type 2 diabetes, cardiovascular disease and other illnesses associated with premature morbidity and death, according to a new study published in JAMA Psychiatry. Antipsychotics are used to treat adults and children with schizophrenia and other conditions including bipolar disorder and irritability with autism. But they are commonly used off-label to treat nonpsychotic disruptive behaviors, like attention-deficit hyperactivity disorder (ADHD), in children and adolescents. ... Read More
The 2017-2018 flu season was the deadliest for children in nearly a decade with 172 reports of pediatric flu deaths since October compared to 171 during the 2012-2013 flu season. Typically, about 110 children die from the flu each season, according to the Centers for Disease Control and Prevention (CDC). As bad as the season was last year, it did not surpass the 2009-2010 season, during which a rare pandemic involving a new strain of influenza killed more than 300 children. (The CDC only began counting pediatric flu deaths in 2004.) One thing that contributed to the higher number of ... Read More
Dozens of people have filed lawsuits against Sorin Group USA and its parent company Sorin Group Deutschland GMBH in Germany alleging the company should have done more to prevent deadly bacterial infections in heart surgery patients who were treated with the company’s Stöckert 3T Heater-Cooler device. Heater-cooler devices are commonly used during cardiothoracic surgeries, as well as other medical and surgical procedures, to warm or cool a patient in order to optimize medical care and improve patient outcomes. The devices have water tanks that provide temperature-controlled water to external heat exchanges or warming/cooling blankets through closed circuits. The water does ... Read More
Consumers should not purchase or use the diet pill called PAYA Dietary Supplement because a laboratory analysis conducted by the Food and Drug Administration (FDA) confirmed that the product contains a hidden drug that puts consumers’ lives at risk. The product was identified by the FDA during an examination of international mail shipments. The PAYA Dietary Supplement is laced with sibutramine, a controlled substance that was pulled from the market in October 2010 for safety reasons. Sibutramine was marketed as an anti-obesity drug under the brand name Meridia, but was banned after a clinical trial revealed that those taking the ... Read More
The Food and Drug Administration (FDA) wants Innovative BioDefense Inc., and Colette Cozean, the company’s president and chief executive officer, to stop selling Zylast topical antiseptics – hand sanitizers, hand washes and lotions that claim to prevent infections like the norovirus, rotavirus, flu, MRSA and Ebola. Not only are the claims outrageous, the products have not been proven safe or effective for these uses, the agency cautioned in a News Release. “Despite being warned by the FDA about their unproven claims, this company has continued to market their products as a tool for preventing infection from serious disease-related pathogens, without ... Read More
Maquet Datascope Corp., is recalling more than 2,800 CARDIOSAVE Hybrid Intra-aortic Balloon Pumps (IABPs) distributed nationwide due to a design defect that can lead to pump malfunction, which could result in serious and potentially fatal health consequences to patients. The recall is listed as a Class I, which is the most serious type of recall. Use of these devices may cause serious injuries or death. CARDIOSAVE Hybrid Intra-aortic Balloon Pumps (IABPs) are cardiac-assist devices used with patients undergoing cardiac and non-cardiac surgery, and to treat patients with acute coronary syndrome or complications from heart failure. Marquet Datascope is recalling the ... Read More